Evidence and expertise combined in therapy specific reports.
IMS' syndicate of reports draws on the expertise of its healthcare editors and researchers and IMS gold standard data to bring unique insight into some of the fastest-growing and most challenging therapy classes worldwide
IMS Therapy Reports cover:
-
New for December 2006: ASTHMA & COPD
-
Neurodegenerative Disease N5A
-
Thrombosis B01
-
Dyslipidemia C10A
-
Diabetes A10
Our Therapy Reports offer:
-
Gold-standard global data from IMS: Comprehensive data which is accessible and easily manipulated allows you to explore and test your own strategies and optimize your performance.
-
Industry-leading opinion from key sector players: Including Industry & Market strategists, Healthcare professionals, Academics and Healthcare policy advisors
-
Insightful forecasting and proven methodologies: Using proven methodologies to indicate likely outcomes in the featured diseases.
-
Analysis of key market drivers, diagnosis and prescribing profiles.
-
Available in hard copy of PDF formats.
For further information, an overview of each report and free downloads, executive summaries and contents, click on the relevant report.
More about this offering
Next Steps
